Annual report pursuant to Section 13 and 15(d)

Nature of Operations and Basis of Presentation (Details Textual)

v3.10.0.1
Nature of Operations and Basis of Presentation (Details Textual) - USD ($)
Sep. 30, 2018
Sep. 30, 2017
Mar. 30, 2016
Nature of Operations and Basis of Presentation (Textual)      
Common stock, shares issued 16,198,791 8,345,844  
Prepaid expenses $ 57,732 $ 220,246  
Accounts payable 1,573,444 602,431  
Accrued expenses 181,657 560,918  
Accrued interest 57,854 42,209  
Notes payable 172,970 172,970  
Common stock options value outstanding 16,199 8,346  
Goodwill $ 1,586,796 $ 1,586,796  
Common stock, par value $ 0.001 $ 0.001  
Acquisition of Leonard-Meron Biosciences, Inc. [Member]      
Nature of Operations and Basis of Presentation (Textual)      
Common stock, shares issued     1,942,456
Issued and outstanding common stock     41.00%
Converted common stock warrants outstanding     243,020
Common stock options outstanding     77,252